Key Quantitative Figures
Preferential Issue (October 25, 2024 allotment):
- Amount raised: ₹4.94 crores (25% upfront consideration)
- Securities issued: 2,92,000 Equity Shares and 19,20,000 Equity Convertible Warrants of face value ₹10 each
Rights Issue (March 24, 2026 allotment):
- Amount raised: ₹22.03 crores (gross proceeds)
- Securities issued: 29,38,500 fully paid-up equity shares of face value ₹10 each
- Issue price: ₹75 per share (including ₹65 share premium)
- Ratio: 1 rights equity share for every 2 existing equity shares
Fund Utilization Details
Preferential Issue Funds (Fully utilized):
- Investment in shares & securities: ₹4.672 crores utilized
- Working capital requirements: ₹0.2688 crores utilized
- No unutilized funds as of March 31, 2026
Rights Issue Funds (Partially utilized):
- Investment in shares & securities and mutual funds: ₹13.55 crores utilized
- Investment in liquid funds for SEBI net worth requirement: ₹2.78 crores utilized
- General corporate purposes: ₹0 utilized (balance ₹5.4 crores to be utilized in FY2026-27)
- Issue-related expenses: ₹0.18 crores utilized (balance ₹0.12 crores to be utilized in FY2026-27)
- Total unutilized balance: ₹5.52 crores currently held in monitoring account/fixed deposits
Dates and Approvals
- Date of statement: May 25, 2026
- Audit Committee review date: May 25, 2026
- Board meeting date: May 25, 2026
- Preferential issue allotment date: October 25, 2024
- Rights issue allotment date: March 24, 2026
Parties Involved
- Listed entity: Nexo Me Capital Markets Limited (formerly SMIFS Capital Markets Limited)
- Monitoring agency for rights issue: CARE Ratings Limited
- Signatories: Sanjana Gupta (Company Secretary-cum-Compliance Officer), Shreemanta Banerjee (CFO cum Vice President Finance and Taxation)
Additional Information
- The statement has been uploaded to company website: www.nexomecap.com
- Company CIN: L74300WB1983PLC036342